Abstract TH848: Explainable Machine Learning-Based Identification of Clinical and Nutritional Determinants of Cardiovascular Diseases

M Minh Le T Thien Vu (National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan) T Tuan Vinh (University of Oxford, Oxford, United Kingdom) D Dang Nguyen H Han Huynh (Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan) L Le Kim Chi Nguyen (National Cerebral and Cardiovascular Center, Suita, Osaka, Japan) T Tu N Nguyen (Woolcock Institute of Medical Research, Ho Chi Minh, Viet Nam) T Thanh T. Nguyen (University of Sydney, Sydney, New South Wales, Australia) T Thu Huynh Minh Le (Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States) L Lam Chau (Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States) H Heath Rutledge-Jukes (Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States) P Pallavi Jonnalagadda (Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States) C Cameron Sabet (Georgetown University School of Medicine, Washington, District of Columbia, United States) P Perisa Ashar (Duke University, Durham, North Carolina, United States) K Ketan Tamirisa (Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States) O Olabiyi Olaniran (North Carolina A&T State University, Greensboro, North Carolina, United States) Y Yayoi Natsume-Kitatani (National Institutes of Biomedical Innovation, Health, and Nutrition,, Osaka, Japan) T Thanh-Huy Nguyen (Carnegie Mellon University, Pittsburgh, Pennsylvania, United States) T Tam Tran M Min Xu P Phat Huynh (North Carolina A&T State University, Greensboro, North Carolina, United States) J Jacques Kpodonu (Harvard Medical School, Boston, Massachusetts, United States) N Nguyen Quoc Khanh Le (Taipei Medical University, Houston, Texas, United States)

Abstract

Background: Cardiovascular diseases (CVDs) remain the leading cause of death globally. Traditional risk models have emphasized adverse clinical factors, yet very few studies jointly quantify potentially protective nutritional influences alongside clinical measures. Hypothesis: We hypothesize that integrating clinical and dietary variables will accurately discriminate prevalent CVDs, with age, hypertension, kidney function, and lipid measures as dominant features; and SHapley Additive exPlanations (SHAP) will provide clinically coherent directions of effect. Methods: We conducted a retrospective cross-sectional analysis of adults ≥20 years from the NHANES dataset. Prevalent CVDs were defined by self-reported heart failure, coronary heart diseases, angina, myocardial infarction, or stroke. Elastic-net (EN) logistic regression, random forest (RF), and XGBoost machine learning (ML) models were trained using an 80/20 stratified split. Test-set performance was assessed with area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, specificity, precision, and F1 score. Predictor contributions were interpreted with SHAP for clinical-only, intake-only, and combined models. Results: Among 22,516 participants, 2,502 (11.1%) reported CVDs. All ML models demonstrated strong discrimination: AUROC = 0.862 for XGBoost, AUROC = 0.857 for EN, and AUROC = 0.854 for RF. XGBoost achieved the highest accuracy of 0.769; sensitivity was highest for RF (0.836). Precision ranged 0.278-0.298; and the highest F1 was 0.434 for XGBoost. SHAP results were clinically concordant. In the clinical-only model, age, hypertension, lower eGFR, smoking, and lipid measures were most influential; diabetes and HbA1c contributed moderately. In the intake-only model, higher potassium, protein, calcium, iron, folate, and vitamin D intakes were among the most informative features. In the combined model, age and hypertension remained dominant, with additional contributions from non-HDL cholesterol, income-to-poverty ratio, eGFR, diabetes, bilirubin, smoking, HbA1c, and HDL. Conclusions: Age and hypertension were the principal determinants, with kidney function and lipid measures strongly influential; dietary patterns added smaller, complementary contributions. Findings support interpretable, ML-based risk profiling that integrates routine clinical data with lifestyle information while acknowledging the need for rigorous phenotype definitions.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (23)

M

Minh Le

T

Thien Vu

National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan

T

Tuan Vinh

University of Oxford, Oxford, United Kingdom

D

Dang Nguyen

H

Han Huynh

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

L

Le Kim Chi Nguyen

National Cerebral and Cardiovascular Center, Suita, Osaka, Japan

T

Tu N Nguyen

Woolcock Institute of Medical Research, Ho Chi Minh, Viet Nam

T

Thanh T. Nguyen

University of Sydney, Sydney, New South Wales, Australia

T

Thu Huynh Minh Le

Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States

L

Lam Chau

Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States

H

Heath Rutledge-Jukes

Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States

P

Pallavi Jonnalagadda

Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States

C

Cameron Sabet

Georgetown University School of Medicine, Washington, District of Columbia, United States

P

Perisa Ashar

Duke University, Durham, North Carolina, United States

K

Ketan Tamirisa

Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States

O

Olabiyi Olaniran

North Carolina A&T State University, Greensboro, North Carolina, United States

Y

Yayoi Natsume-Kitatani

National Institutes of Biomedical Innovation, Health, and Nutrition,, Osaka, Japan

T

Thanh-Huy Nguyen

Carnegie Mellon University, Pittsburgh, Pennsylvania, United States

T

Tam Tran

M

Min Xu

P

Phat Huynh

North Carolina A&T State University, Greensboro, North Carolina, United States

J

Jacques Kpodonu

Harvard Medical School, Boston, Massachusetts, United States

N

Nguyen Quoc Khanh Le

Taipei Medical University, Houston, Texas, United States